FindTrial
Sign In

The study on the biomarker for diagnosis and curative evaluation of breast cancer

The study on biomarker for diagnosis and curative evaluation of breast cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-RCC-10000841
Enrollment
Unknown
Registered
2010-04-16
Start date
2008-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer

Interventions

Gold Standard:
Index test:

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: all patients with breast cancer

Exclusion criteria

Exclusion criteria: NA

Design outcomes

Primary

MeasureTime frame
biomarker of DNA in serum or tumor tissu;—

Countries

China

Contacts

Public ContactHong Zheng
hongzheng11@gmail.com+86 028 85422685

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026